S565-0551 Screening compound: 5-[3-(4-ethyl-4H-1,2,4-triazol-3-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-methoxypyridine

S565-0551 Screening compound: 5-[3-(4-ethyl-4H-1,2,4-triazol-3-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-methoxypyridine
S565-0551 Screening compound: 5-[3-(4-ethyl-4H-1,2,4-triazol-3-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-methoxypyridine alternative view

Chemical Structure Depiction of ChemDiv screening compound S565-0551
5-[3-(4-ethyl-4H-1,2,4-triazol-3-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-methoxypyridine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S565-0551

Molecular Formula

C18H21N7O2 (C18 H21 N7 O2)

Compound Name

5-[3-(4-ethyl-4H-1,2,4-triazol-3-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-methoxypyridine

IUPAC name

5-[3-(4-ethyl-4H-124-triazol-3-yl)-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridine-5-carbonyl]-2-methoxypyridine

SMILES

CCn1c(-c2nn(C)c(CC3)c2CN3C(c(cc2)cnc2OC)=O)nnc1

InChI

InChI=1S/C18H21N7O2/c1-4-24-11-20-21-17(24)16-13-10-25(8-7-14(13)23(2)22-16)18(26)12-5-6-15(27-3)19-9-12/h5-6,9,11H,4,7-8,10H2,1-3H3

InChI Key

QMKLADCIUWKYFM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD32010336

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

367.41

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.002

Distribution Coefficient, logD

-0.015

Water Solubility, LogSw

-1.37

Polar Surface Area

72.229

Acid Dissociation Constant (pKa)

19.88

Base Dissociation Constant (pKb)

5.99

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.89

S565-0551 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

CNS Targets (44014 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Nervous system
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with S565-0551 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S565-0551?
Check Price and Availability of S565-0551, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S565-0551 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S565-0551
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S565-0551
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S565-0551 available by request